Overview

A Trial of Wellbutrin for Crohn's Disease

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The investigators are testing the hypothesis that Wellbutrin (bupropion) can give a clinical remission in Crohn's disease.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Altschuler, Eric, M.D.
Collaborator:
GlaxoSmithKline
Treatments:
Bupropion